FindTrial
Sign In

EVALUATION OF HAIR SHEDDING AND IMPROVEMENT WITH NUTRACEUTICALS IN PATIENTS WITH AGA

AN OPEN LABELLED OBSERVATIONAL STUDY TO EVALUATE THE SCALP HAIR SHEDDING AND IMPROVEMENT IN TELOGEN PERCENTAGE IN PATIENTS WITH AGA USING NUTRACEUTICALS- L-CARNITINE, RESVERATEROL, CURCUMIN. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108805
Enrollment
500
Registered
2026-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr. Rachita Dhurat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Male patients with AGA 3V and above Norwood Hamilton Grading, with hair fall more than 6months, Hair pull test positive, in good health, and willing to participate Female patients with FPHL 1-3 Sinclair Grading on trichoscopy with Hair Diameter Diversity more than 20 percent with hair count more than 100 per day and/or hair pull test positive, in good health and willing to participate

Exclusion criteria

Exclusion criteria: Patients with history of acute illnes or known comorbidities, smokers tobacco users On systemic or topical minoxidil, topicalsteroids, or hair growth serums for AGA more than equal to grade 3 prior to study. Individuals with history of alopecia areata, scarring alopecia, trichotillomania,Telogen effluvium ,known thyroid disorders

Design outcomes

Primary

MeasureTime frame
1. Improvement in telogen percentage on trichogram in patients with AGA/FPHLTimepoint: 6 months—

Secondary

MeasureTime frame
1. Improvement in Hair Pull test 2. Improvement in Hair SheddingTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Rachita Dhurat

Lokmanya Tilak Municipal Medical college and Hospital

drrachitadhurat@gmail.com9870390057

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026